Fenebrutinib is a new treatment from the BTK inhibitor class, which aims to target immune cells throughout the body including the brain and spinal cord to treat MS.
CEO Rohan Greenland reflects on the growing international collaboration driving advances in MS research, treatment and care. He highlights how shared initiatives – from new diagnostic criteria to joint clinical trials – are helping the global MS community move faster toward cures.
ECTRIMS 2025 spotlighted global advances in MS research, diagnosis, treatment, and prevention under the theme ‘A New Era of Precision’.
Kate shares her experience of living with MS, building a career in IT, mentoring women in her field and providing peer support within the MS community, perspectives she now brings to her role on the LEEP.
An international expert workshop has reviewed the complexities in managing MS in older age, finding knowledge gaps and providing recommendations for the field.
Largest study yet shows menopause does not impact disability progression in women living with MS.
InforMS is a new app helping Australian MS Longitudinal Study (AMSLS) participants manage MS by tracking symptoms, storing health data, and contributing to research, making care more personal and impactful.
CEO Rohan Greenland shares five areas of special interest he’s watching closely as the world’s largest MS research congress, ECTRIMS, takes place in Barcelona.
The International Progressive MS Alliance has collated MRI and clinical data from over 13,000 people to answer big questions in progressive MS.
